In addition to improving TG levels in patients with diabetes mellitus, this analysis found that, compared with placebo, treatment with IPE 4 g/day also significantly decreased placebo-adjusted non–HDL-C, VLDL-C, Lp-PLA2, Apo B, TC, HDL-C, VLDL-TG, and hsCRP. The gene discussed is APOB; the disease is diabetes mellitus.